Trigeminal Neuralgia Treatment Guidelines

Introduction to Trigeminal Neuralgia

• Trigeminal neuralgia is characterized by sudden, unilateral, severe, brief, stabbing, recurrent episodes of pain in the distribution of one or more branches of the trigeminal nerve, with a profound negative impact on quality of life 1, 2

First-Line Pharmacological Treatment

• The American Academy of Neurology recommends carbamazepine as the first-line treatment of choice for trigeminal neuralgia, with oxcarbazepine being an equally effective alternative with fewer side effects 1, 2
• Carbamazepine has an efficacy of 70% of patients showing partial or complete pain relief, and its mechanism is as a sodium channel-blocker 3

Monitoring and Adjustments

• Common side effects of carbamazepine include drowsiness, headache, dizziness, dry mouth, constipation, and sedation, which may lead to treatment discontinuation in approximately 27% of patients 3, 4

Second-Line and Adjunctive Medications

• Lamotrigine, baclofen, gabapentin, pregabalin, and nortriptyline are considered as second-line or adjunctive medications for trigeminal neuralgia, with some evidence of efficacy 1, 2, 3

Surgical Options

• Microvascular decompression is the most effective surgical option for long-term pain relief, with a 70% chance of being pain-free at 10 years, but carries risks including hearing loss and mortality 1, 2
• Ablative procedures such as radiofrequency thermocoagulation, glycerol rhizotomy, balloon compression, and Gamma Knife radiosurgery are considered for patients who cannot undergo major surgery, resulting in varying degrees of sensory loss 1, 2, 5